Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis and Alzheimer's disease are fundamentally different diseases. However, recent data suggest that certain mechanisms of neurodegeneration may be shared between the two diseases. Inflammation drives the disease in multiple sclerosis. It is also present in Alzheimer's disease lesions, where it may have dual functions in amyloid clearance as well as in the propagation of neurodegeneration. In both diseases, degeneration of neurons, axons, and synapses occur on the background of profound mitochondrial injury. Reactive oxygen and nitric oxide intermediates are major candidates for the induction of mitochondrial injury. Radicals are produced through the induction of the respiratory burst in activated microglia, which are present in the lesions of both diseases. In addition, liberation of toxic iron from intracellular stores may augment radical formation. Finally reactive oxygen species are also produced in the course of mitochondrial injury itself. Anti-oxidant and mitochondria protective therapeutic strategies may be beneficial both in multiple sclerosis and Alzheimer's disease in particular in early stages of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibrinogen-induced CD11b/CD18 receptor-mediated microglia activation instigates the generation and release of neurotoxic reactive oxygen species (ROS) via nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which is upregulated in neurodegenerative diseases (Haslund-Vinding et al., 2017; Lassmann, 2011; Ryu et al., 2018).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Lassmann, 2011
In the citing paper
“which is upregulated in neurodegenerative diseases (Haslund-Vinding et al., 2017; Lassmann, 2011; Ryu et al., 2018).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Lassmann, 2011
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · cited 1×
“Vaccination studies with Aß have shown in experimental animals as well as in humans that the deposition of amyloid plaques can be prevented (Schenk et al. 1999) or that existing amyloid plaques can be dissolved in the presence of specific auto-antibodies against the Aß molecule (Bard et al. 2000).”
BackgroundOxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 2×
“As in multiple sclerosis there is good biochemical evidence in Alzheimer’s disease for oxidative injury in the affected cortex, which seems to be a very early event in the pathogenesis of cortical pathology (Nunomura et al. 2001; Markesbery and Lovell 1998; Reed et al. 2009; Butterfield et al. 2010).”
BackgroundMultiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 2×
“The alternative concept is that neurodegeneration becomes independent from inflammation or that inflammation seen in pathology may be a secondary consequence of neurodegeneration ( Trapp and Nave 2008 ).”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 2×
“…by experimental studies, which show that systemic infections lead to profound immune stimulation in the central nervous system, which promotes neurodegeneration in scrapie, another neurodegenerative disease associated with deposition of misfolded proteins in the nervous system (Perry et al. 2010).”
BackgroundResultThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationThe effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 1×
“Unfortunately, however, in humans clearance of amyloid plaques in AD patients had no influence on the progression of dementia and did not affect tau-pathology within the lesions (Holmes et al. 2008).”
BackgroundNeuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 2×
“As with active Aß-immunization (Nicoll et al. 2003), autoimmune brain inflammation may also be induced by tau-vaccination (Rosenmann et al. 2006).”
BackgroundMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 1×
“In AD reduced numbers of mitochondria were present within neurons showing increased oxidative damage, and mtDNA and COX activity was found in vacuoles, associated with lipofuscin (Hirai et al. 2001; Castellani et al. 2002; Moreira et al. 2010).”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationSystemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 2×
“On the other hand, recent studies suggest that concomitant systemic infections are associated with more rapid disease progression in AD (Holmes et al. 2009).”
BackgroundOxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · cited 2×
“Interestingly, mitochondrial DNA (Mecocci et al. 1994) was found to be more severely affected by oxidation compared to nuclear DNA (Te Koppele et al. 1996).”
BackgroundMitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Dröse, S., Brandt, U., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905529106 · Cited by 655
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · cited 1×
“In the latter it was proposed that mitochondrial injury leads to a state of ‘‘virtual hypoxia’’ (Dutta et al. 2006; Trapp and Stys 2009).”
BackgroundMonocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Self-citationBolaños, J. P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J. B., & Heales, S. J. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062227.x · Cited by 519
Asuni, A. A., Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2361-07.2007 · Cited by 506 · cited 1×
“Recent experimental studies suggest that vaccination against tau proteins may similarly promote clearance of phosphorylated tau-protein aggregates (Asuni et al. 2007; Boutajangout et al. 2010).”
BackgroundNSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498 · cited 1×
“However, therapeutic trials of AD patients with anti-inflammatory agents have so far been disappointing (McGeer and McGeer 2007, McGeer et al. 2006).”
BackgroundOccurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., & Kosaka, K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00496-9 · Cited by 481 · cited 2×
“B-lymphocytes, macrophages, and activated microglia are seen in the brain of patients with Alzheimer’s disease and inflammation increases with progression of neuropathological alterations (Togo et al. 2002).”
BackgroundMitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
Self-citationBrain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · cited 2×
“It is present in neurodegenerative lesions (Hallgren and Sourander 1960; Jellinger et al. 1990) and has been suggested to play a role in neurodegeneration in the aging brain and age related neurodegenerative diseases (Perry et al. 2002).”
BackgroundMitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406 · cited 1×
“Mitochondrial injury in active MS lesions mainly affects complex IV of the respiratory chain and is seen in axons, oligodendrocyte as well as in astrocytes (Mahad et al. 2008).”
BackgroundSelf-citationMitochondrial DNA deletions and neurodegeneration in multiple sclerosis
Campbell, G. R., Ziabreva, I., Reeve, A. K., Krishnan, K. J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2011) · Annals of Neurology · doi:10.1002/ana.22109 · Cited by 386
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., & Lassmann, H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.25 · Cited by 330
Self-citationRadical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 318
de la Monte, S. M., & Wands, J. R. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9209 · Cited by 316
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Butterfield, D. A., Bader Lange, M. L., & Sultana, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.005 · Cited by 299
Activation of NADPH Oxidase in Alzheimer’s Disease Brains
Shimohama, S., Tanino, H., Kawakami, N., Okamura, N., Kodama, H., Yamaguchi, T., Hayakawa, T., Nunomura, A., Chiba, S., Perry, G., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2897 · Cited by 292
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-10.2010 · Cited by 272
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.
Wilkinson, B. L., & Landreth, G. E. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-30 · Cited by 266
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Witte, M. E., Geurts, J. J. G., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.014 · Cited by 235
Montine, K. S., Olson, S. J., Amarnath, K., Whetsell, W. O., Graham, D. G., & Montine, T. J. (1997) · Europe PMC (PubMed Central) · Cited by 231
Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years
McGeer, P. L., Rogers, J., & McGeer, E. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s330 · Cited by 227
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
Tauopathy-like Abnormalities and Neurologic Deficits in Mice Immunized With Neuronal Tau Protein
Rosenmann, H., Grigoriadis, N., Karussis, D., Boimel, M., Touloumi, O., Ovadia, H., & Abramsky, O. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1459 · Cited by 178
Evidence for Polygenic Susceptibility to Multiple Sclerosis—The Shape of Things to Come
The International Multiple Sclerosis Genetics Consortium (IMSGC) (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.02.027 · Cited by 169
Frenkel, D., Maron, R., Burt, D. S., & Weiner, H. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23241 · Cited by 167
Sharma, R., Fischer, M.-T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., Fujihara, K., Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0704-z · Cited by 164
Self-citationDysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Self-citationAlzheimer 100 – highlights in the history of Alzheimer research
Jellinger, K. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0578-3 · Cited by 159
Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
Eckert, A., Schulz, K. L., Rhein, V., & Götz, J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8109-5 · Cited by 157
Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Higgins, G. C., Beart, P. M., Shin, Y. S., Chen, M. J., Cheung, N. S., & Nagley, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100321 · Cited by 156
Mitochondria and the Link Between Neuroinflammation and Neurodegeneration
Di Filippo, M., Chiasserini, D., Tozzi, A., Picconi, B., & Calabresi, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100543 · Cited by 154
Montine, K. S., Reich, E., Neely, M. D., Sidell, K. R., Olson, S. J., Markesbery, W. R., & Montine, T. J. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00005 · Cited by 153
Devi, L., & Anandatheerthavarada, H. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.007 · Cited by 150
RNA oxidation in Alzheimer disease and related neurodegenerative disorders
Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0508-1 · Cited by 148
Perry, G. L., Sayre, L. M., Atwood, C., Castellani, R. J., Cash, A., Rottkamp, C. A., & Smith, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00006 · Cited by 141
Gandhi, K. S., McKay, F. C., Cox, M., Riveros, C., Armstrong, N., Heard, R. N., Vucic, S., Williams, D. W., Stankovich, J., Brown, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq090 · Cited by 138
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
Nunomura, A., Chiba, S., Lippa, C. F., Cras, P. P., Kalaria, R. N., Takeda, A., Honda, K., Smith, M. A., & Perry, G. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.003 · Cited by 136
Multiple sclerosis and Alzheimer's disease
Dal Bianco, A., Bradl, M., Frischer, J., Kutzelnigg, A., Jellinger, K., & Lassmann, H. (2008) · Annals of Neurology · doi:10.1002/ana.21240 · Cited by 123
Self-citationInhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., Borgulya, G., Sumegi, B., Komoly, S., Gallyas, F., et al. (2010) · Brain · doi:10.1093/brain/awp337 · Cited by 107
Self-citationNOX Activity Is Increased in Mild Cognitive Impairment
Bruce-Keller, A. J., Gupta, S., Parrino, T. E., Knight, A. G., Ebenezer, P. J., Weidner, A. M., LeVine, H., Keller, J. N., & Markesbery, W. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2823 · Cited by 104
Ziabreva, I., Campbell, G., Rist, J., Zambonin, J., Rorbach, J., Wydro, M. M., Lassmann, H., Franklin, R. J. M., & Mahad, D. (2010) · Glia · doi:10.1002/glia.21052 · Cited by 102
Self-citationMultiple sclerosis therapeutics: Unexpected outcomes clouding undisputed successes
Wiendl, H., & Hohlfeld, R. (2009) · Neurology · doi:10.1212/01.wnl.0000344417.42972.54 · Cited by 96
THE NON‐HAEMIN IRON IN THE CEREBRAL CORTEX IN ALZHEIMER'S DISEASE
Hallgren, B., & Sourander, P. (1960) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1960.tb13369.x · Cited by 88
Protein co-expression with axonal injury in multiple sclerosis plaques
Diaz-Sanchez, M., Williams, K., DeLuca, G. C., & Esiri, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0045-0 · Cited by 85
Holtzman, D. M. (2008) · Nature · doi:10.1038/454418a · Cited by 48
8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease
Koppele, J. M. T., Lucassen, P. J., Sakkee, A. N., Asten, J. G. V., Ravid, R., Swaab, D. F., & van Bezooijen, C. F. A. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00165-0 · Cited by 44
Emerging multiple sclerosis disease-modifying therapies
Giacomini, P. S., Darlington, P. J., & Bar‐Or, A. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4ca1 · Cited by 22
Cited by
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Oxidative stress in neurodegenerative diseases.
Chen, X., Guo, C., & Kong, J. (2012) · PubMed · doi:10.3969/j.issn.1673-5374.2012.05.009 · Cited by 356
Davalos, D., Kyu Ryu, J., Merlini, M., Baeten, K. M., Le Moan, N., Petersen, M. A., Deerinck, T. J., Smirnoff, D. S., Bedard, C., Hakozaki, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2230 · Cited by 568
Self-citationMerlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
Nava Catorce, M., & Gevorkian, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151204122017 · Cited by 356
Metadata
- Authors
- Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Lassmann, Hans
- ORCID
- Lassmann, Hans
- Venue
- Journal of Neural Transmission
- Published
- 2011-03-05
- Volume
- 118
- Issue
- 5
- Pages
- 747-752
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W1965518966
- Cited by
- 112
- References
- 67
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 1 · 2020: 11 · 2019: 2 · 2018: 9 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 10 · 2013: 13 · 2012: 13
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- multiple sclerosis, Alzheimer's disease, neurodegeneration, shared pathogenesis, neuroinflammation, amyloid clearance, mitochondrial injury, reactive oxygen species, nitric oxide, iron release, oxidative stress, antioxidant therapy, axonal degeneration, synaptic degeneration
- MeSH terms
- Alzheimer Disease, Humans, Inflammation, Mitochondria, Multiple Sclerosis, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.